Mr. President, reserving the right to object--and I appreciate my friend--I do consider him my friend--and colleague and his concern, which we mutually share on this issue. But this legislation was introduced 7 days ago--7 days ago. Most…
Mr. President, reserving the right to object--and I appreciate my friend--I do consider him my friend--and colleague and his concern, which we mutually share on this issue. But this legislation was introduced 7 days ago--7 days ago. Most of our colleagues have not even had a chance to read it.
The Foreign Relations Committee, which I have the privilege of chairing, has not reviewed or marked up this bill since it just got referred to us. And to my knowledge, my colleague has not made any effort to engage the committee.
Especially in light of its sweeping and mandatory nature and the lack of any waiver--even if a waiver were in our national interest--members with expertise in foreign affairs need to have the opportunity to scrutinize the bill.
Regular order allows us to refine legislation. It ensures we avoid unintended consequences, and that is needed here.
As chairman of the Foreign Relations Committee, I take the threat of Mexican drug trafficking organizations seriously. During my 30 years in Congress, I have made significant efforts to combat drug trafficking in Mexico, Latin America, the Caribbean, and around the world.
Given the potential impact of this legislation, I would just ask my colleague the following questions for his consideration--these are the questions I ask myself as I am looking at his request: The U.S. Congress has developed a framework of sanctions specifically to target drug traffickers. It is called the Kingpin Act. There is substantial overlap between the Kingpin Act and what is being proposed today. Is this redundancy helpful, or is it hurtful? Why is it needed?
S. 4914 provides no new funding for the management of our sanctions program targeting foreign terrorist organizations, and we are deeply engaged in our whole-sanctions operation as it relates to Russia and Ukraine. This would be additional, but it has no additional resources. Do we want to stretch the U.S. Government's personnel and resources that target foreign terrorist organizations? That is what the legislation would do.
Does my colleague want to explain to the American people why we should have less personnel and funding dedicated to countering Hezbollah, ISIS, al-Qaida, because, as it is, that is what the legislation would do.
The members of the Foreign Relations Committee take the threat posed by Mexican cartels very seriously. We know that the cartels are deeply involved in the production and trafficking of fentanyl. We know that this is a substance so lethal it kills tens of thousands of American citizens every year.
That is why in June, the committee approved the FENTANYL Results Act, legislation designed to strengthen the United States response to fentanyl trafficking--legislation that received unanimous, bipartisan backing of all members of the Foreign Relations Committee, legislation that we hope can be enacted into law before the end of this Congress. That is a serious legislative effort conducted through normal order of the Senate.
I would just say to my friend, if you really want to address the impact that Mexican cartels and drug trafficking have on the American people, I urge you, respectfully, to work through the Foreign Relations Committee and join us in a meaningful legislative effort.
Finally, before I object, I would just say, I know that my colleague keeps talking about the Biden open borders. Well, it is a little incongruous when you self-designate and made in your comments that it is the U.S. Customs and Border large catches of fentanyl and other drugs under the direction of this administration that is making those catches. It is either that we have an open border and anything comes in, or it is that the U.S. Customs and Border Patrol that is actively engaged is stopping the flow of significant amounts of drugs.
For all of those reasons, at this point in time, I will have to object.
Mr. President, I can't let the question rhetorically hang there.
I would say to my colleague, first of all, for all of us who have been fighting this issue on a bipartisan basis--I think his bill has only got Republican sponsors on it, a few--that we have been fighting this, and this is a continuous fight. And, yes, every life that is lost is a life that we mourn. But what would I say to them?
I would say, well, if we get the Fentanyl Results Act legislation passed, which passed the committee on a bipartisan basis, we would have a bipartisan approach toward dealing with this.
I appreciate that my colleague has declared war on fentanyl, but just because he has declared war doesn't mean that his view as to how you meet the challenge is the ultimate result, is the ultimate solution.
So in good faith, I offer our colleague to work with us. But you can't end up making the Senate the Committee of the Whole. If we want to do that, good, let's abolish all of our committees, and let's all sit here and we can bring up legislation after legislation that was just introduced, where nobody has a chance to read it and nobody has a chance to understand the unintended consequences, as noble as the intent might be. But that is what my colleague has done on more than one occasion now. He introduces a piece of legislation and, days after, comes to the floor to seek its approval. Well, that bypasses the entire system that is meant as a check and balance to get the best legislation to accomplish a common goal.
So that is what I would say. We need to work on this together. We are committed to it. That is why we passed legislation in the past. That is why we just passed legislation recently. I hope my colleague will join us, and maybe we can get it in the NDAA together.
With that, I yield the floor.